These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 28219328
1. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes. Donadio C, Tognotti D, Caponi L, Paolicchi A. BMC Nephrol; 2017 Feb 20; 18(1):68. PubMed ID: 28219328 [Abstract] [Full Text] [Related]
4. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A. Cochrane Database Syst Rev; 2001 Feb 20; (3):CD003234. PubMed ID: 11687058 [Abstract] [Full Text] [Related]
5. Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures. Bargnoux AS, Buthiau D, Morena M, Rodriguez A, Noguera-Gonzalez ME, Gilbert O, Le Quintrec M, Kuster N, Cristol JP. Artif Organs; 2020 Jun 20; 44(6):647-654. PubMed ID: 31951029 [Abstract] [Full Text] [Related]
6. Estimating residual kidney function in dialysis patients without urine collection. Shafi T, Michels WM, Levey AS, Inker LA, Dekker FW, Krediet RT, Hoekstra T, Schwartz GJ, Eckfeldt JH, Coresh J. Kidney Int; 2016 May 20; 89(5):1099-1110. PubMed ID: 26924062 [Abstract] [Full Text] [Related]
7. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Lindström V, Grubb A, Alquist Hegbrant M, Christensson A. Scand J Clin Lab Invest; 2008 May 20; 68(8):685-91. PubMed ID: 18609120 [Abstract] [Full Text] [Related]
9. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein. Donadio C. Am J Physiol Renal Physiol; 2010 Dec 20; 299(6):F1407-23. PubMed ID: 20844024 [Abstract] [Full Text] [Related]
11. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial. Chazot C, Kirchgessner J, Pham J, Vo-Van C, Lorriaux C, Hurot JM, Zaoui E, Grassmann A, Jean G, Marcelli D. Nephron; 2015 Dec 20; 129(4):269-75. PubMed ID: 25825336 [Abstract] [Full Text] [Related]
16. β-Trace protein in hemodialysis - comparison of different therapy modalities and high flux dialyzers. Schwab S, Bös D, Hundt F, Kleine CE, Strassburg CP, Woitas RP. Clin Chem Lab Med; 2018 Oct 25; 56(11):265-267. PubMed ID: 29715180 [No Abstract] [Full Text] [Related]
17. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time. van Craenenbroeck AH, Bragfors-Helin AC, Qureshi AR, Lindholm B, Sjöberg B, Anderstam B, Heimburger O, Stenvinkel P, Bárány P. Kidney Blood Press Res; 2017 Oct 25; 42(5):877-885. PubMed ID: 29161688 [Abstract] [Full Text] [Related]
18. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Stein G, Franke S, Mahiout A, Schneider S, Sperschneider H, Borst S, Vienken J. Nephrol Dial Transplant; 2001 May 25; 16(5):999-1008. PubMed ID: 11328907 [Abstract] [Full Text] [Related]